[Skip to Content]
[Skip to Content Landing]
Article
October 1990

Mae III Positively Detects the Mitochondrial Mutation Associated With Type I Leber's Hereditary Optic Neuropathy

Author Affiliations

From the Departments of Ophthalmology (Drs Stone and Kardon and Mr Coppinger) and Biochemistry (Dr Donelson), The University of Iowa College of Medicine, The Howard Hughes Medical Institute, Iowa City.

Arch Ophthalmol. 1990;108(10):1417-1420. doi:10.1001/archopht.1990.01070120065030
Abstract

• Leber's hereditary optic neuropathy is a blinding disease that usually causes acute or subacute central visual loss in adolescent and young adult males. In patients who lack a family history of a similar illness, Leber's disease has been a diagnosis of exclusion. The recent discovery of a specific mitochondrial mutation in many pedigrees affected with the disease has provided the basis for rapid molecular diagnosis of one genetic type of Leber's disease. We have developed a new method, based on a Mae III (Boehringer Mannheim Biochemicals, Indianapolis, Ind) restriction fragment length polymorphism, for detecting the Wallacetype Leber's mutation. The method has several advantages over the previously used SfaN I method that make it more suitable for use as a general laboratory test. We demonstrate the utility of this new test in the diagnosis of Leber's disease in a patient with no family history of visual loss.

References
1.
Van Senus AHC.  Leber's disease in the Netherlands . Doc Ophthalmol . 1963;17:1-161.Article
2.
Smith JL, Hoyt WF, Susac JO.  Ocular fundus in acute Leber optic neuropathy . Arch Ophthalmol . 1973;90:349-354.Article
3.
Nikoskelainen E, Sogg RL, Rosenthal AR, Friberg TR, Dorfman LJ.  The early phase in Leber's hereditary optic atrophy . Arch Ophthalmol . 1977;95:969-978.Article
4.
Nikoskelainen E, Hoyt WF, Nummelin K.  Ophthalmoscopic findings in Leber's hereditary optic neuropathy, I: fundus findings in asymptomatic family members . Arch Ophthalmol . 1982;100:1597-1602.Article
5.
Nikoskelainen E, Hoyt WF, Nummelin K.  Ophthalmoscopic findings in Leber's hereditary optic neuropathy, II: the fundus findings in the affected family members . Arch Ophthalmol . 1983;101:1059-1068.Article
6.
Nikoskelainen E.  New aspects of the genetic, etiologic, and clinical puzzle of Leber's disease . Neurology . 1984;34:1482-1484.Article
7.
Seedorff T.  The inheritance of Leber's disease . Acta Ophthalmol . 1985;63:135-145.Article
8.
Nikoskelainen EK, Savontaus ML, Wanne OP, Katila MJ, Nummelin KU.  Leber's hereditary optic neuroretinopathy: a maternally inherited disease . Arch Ophthalmol . 1987;105:665-671.Article
9.
Berninger TA, Bird AC, Arden GB.  Leber's hereditary optic atrophy . Ophthalmic Paediatr Genet . 1989;10:211-227.Article
10.
Wallace CW, Singh G, Lott MT, et al.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy . Science . 1988;242:1427-1430.Article
11.
Singh G, Lott MT, Wallace DC.  A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy . N Engl J Med . 1989;320:1300-1305.Article
12.
Egger J, Wilson J.  Mitochondrial inheritance in a mitochondrially mediated disease . N Engl J Med . 1983;309:142-146.Article
13.
Novotny EJ, Singh G, Wallace DC, et al.  Leber's disease and dystonia: a mitochondrial disease . Neurology . 1986;36:1053-1060.Article
14.
Wallace DC.  Leber's optic atrophy: a possible example of vertical transmission of a slow virus in man . Aust Ann Med . 1970;3:259-262.
15.
Hotta Y, Hayakawa M, Saito K, Kanai A, Nakajima A, Fujiki K.  Diagnosis of Leber's optic neuropathy by means of polymerase chain reaction amplification . Am J Ophthalmol . 1989;108:601-602.
16.
Yoneda M, Tsuji T, Yamauchi T, et al.  Mitochondrial DNA mutation in family with Leber's hereditary optic neuropathy . Lancet . 1989;1:1076-1077.Article
17.
Holt IJ, Miller DH, Harding AE.  Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy . J Med Genet . 1989;26:739-743.Article
18.
Lott MT, Voljavec AS, Wallace DC.  Variable genotype of Leber's hereditary optic neuropathy patients . Am J Ophthalmol . 1990;109:625-631.
19.
Boyum A.  Isolation of mononuclear cells and granulocytes from human blood . Scand J Clin Lab Invest . 1968;21( (suppl97) ):77-89.Article
20.
Gussow D, Clackson T.  Direct clone characterization from plaques and colonies by the polymerase chain reaction . Nucleic Acids Res . 1989;17:4000.Article
21.
Chen JD, Cox I, Denton MJ.  Preliminary exclusion of an x-linked gene in Leber optic atrophy by linkage analysis . Hum Genet . 1989;82:203-207.Article
22.
Wallace DC, Zheng X, Lott MT, et al.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease . Cell . 1988;55:601-610.Article
23.
Wilson J.  Leber's hereditary optic atrophy: some clinical and aetiological considerations . Brain . 1963;86:347-362.Article
24.
Vilkki J, Savontaus ML, Nikoskelainen EK.  Genetic heterogeneity in Leber's hereditary optic neuroretinopathy revealed by mitochondrial DNA polymorphism . Am J Hum Genet . 1989;45:206-211.
25.
Coppinger JM, Stone EM, Slavin ML, Keller CF, Donelson JE.  Leber's hereditary optic neuropathy in a six generation pedigree with a wild-type ND-4 gene . Invest Ophthalmol Vis Sci . 1990;31( (suppl) ):296.
26.
Ogasahara S, Nishikawa Y, Yorifuji S, et al.  Treatment of Kearns-Sayre syndrome with coenzyme Q10 . Neurology . 1986;36:45-53.Article
27.
Eleff S, Kennaway NRM, Darley-Usmar VM, et al.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle . Proc Natl Acad Sci U S A . 1984;81:3529-3533.Article
×